Compare CLNN & PAAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLNN | PAAI |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.4M | 49.5M |
| IPO Year | 2021 | 2017 |
| Metric | CLNN | PAAI |
|---|---|---|
| Price | $4.39 | $1.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $33.75 | N/A |
| AVG Volume (30 Days) | 119.0K | ★ 4.1M |
| Earning Date | 05-08-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 191.93 |
| EPS | N/A | ★ N/A |
| Revenue | $200,000.00 | ★ $16,892,000.00 |
| Revenue This Year | $17.64 | N/A |
| Revenue Next Year | $19,516.77 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 27.46 |
| 52 Week Low | $3.25 | $0.87 |
| 52 Week High | $13.50 | $3.47 |
| Indicator | CLNN | PAAI |
|---|---|---|
| Relative Strength Index (RSI) | 53.74 | 55.66 |
| Support Level | $3.92 | $0.87 |
| Resistance Level | $4.70 | N/A |
| Average True Range (ATR) | 0.38 | 0.56 |
| MACD | 0.09 | 0.11 |
| Stochastic Oscillator | 96.64 | 25.00 |
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.